Literature DB >> 10073785

Type of alcoholic beverage and risk of myocardial infarction.

J M Gaziano1, C H Hennekens, S L Godfried, H D Sesso, R J Glynn, J L Breslow, J E Buring.   

Abstract

We examined the relation of alcoholic beverage type and risk of myocardial infarction (MI) in a case-control study among 340 cases of MI and an equal number of age-, sex-, and community-matched controls. Alcohol consumption was estimated using a food frequency questionnaire, with alcohol drinkers defined as those consuming > or = 1/2 drink/day on average of any alcoholic beverage. Beer, wine, and liquor drinkers had at least half of their consumption from 1 beverage type. Fasting venous blood samples were obtained and analyzed for lipid profiles. Compared with nondrinkers, after adjustment for age and sex, reductions in risk of MI were similar for regular drinkers of any type of alcoholic beverage (relative risk [RR] 0.54; 95% confidence interval [CI] 0.37 to 0.79; p = 0.001), beer (RR 0.55; 95% CI 0.31 to 0.97; p <0.05), wine (RR 0.48; 95% CI 0.27 to 0.87; p <0.05), and liquor (RR 0.59; 95% CI 0.38 to 0.91; p <0.05) drinkers. Comparable benefits remained apparent even after multivariate adjustment for a wide range of nonlipid coronary risk factors. High-density lipoprotein (HDL) levels were significantly higher in all 4 beverage categories when compared with levels in nondrinkers, and as expected, adjustment for total HDL, a major direct effect of alcohol, substantially attenuated the protective effect in all 4 beverage categories. Relative risks were 0.94 for any beverage, 1.09 for beer, 0.97 for wine, and 0.83 for liquor after further adjustment. This strongly suggests that the protective effect of each beverage type is, in large part, mediated by increased HDL. These data indicate that regular consumption of small to moderate amounts of alcoholic beverages, regardless of the type, reduces the risk of MI, and further suggest that there is benefit, in large part, from increases in HDL levels.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10073785     DOI: 10.1016/s0002-9149(98)00782-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

Review 1.  Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies.

Authors:  Michael A Collins; Edward J Neafsey; Kenneth J Mukamal; Mary O Gray; Dale A Parks; Dipak K Das; Ronald J Korthuis
Journal:  Alcohol Clin Exp Res       Date:  2008-11-19       Impact factor: 3.455

2.  Types of alcoholic beverages and blood lipids in a French population.

Authors:  J-B Ruidavets; P Ducimetière; D Arveiler; P Amouyel; A Bingham; A Wagner; D Cottel; B Perret; J Ferrières
Journal:  J Epidemiol Community Health       Date:  2002-01       Impact factor: 3.710

3.  Longitudinal study of alcohol consumption and HDL concentrations: a community-based study.

Authors:  Shue Huang; Junjuan Li; Gregory C Shearer; Alice H Lichtenstein; Xiaoming Zheng; Yuntao Wu; Cheng Jin; Shouling Wu; Xiang Gao
Journal:  Am J Clin Nutr       Date:  2017-03-01       Impact factor: 7.045

4.  Nonalcoholic components in wine reduce low density lipoprotein cholesterol in normocholesterolemic rats.

Authors:  E Cascón; R Roig; A Ardèvol; M J Salvadó; L Arola; C Bladé
Journal:  Lipids       Date:  2001-04       Impact factor: 1.880

Review 5.  Alcohol consumption and risk of coronary heart disease among individuals with type 2 diabetes.

Authors:  M Tanasescu; F B Hu
Journal:  Curr Diab Rep       Date:  2001-10       Impact factor: 4.810

6.  Interactions of the apolipoprotein A5 gene polymorphisms and alcohol consumption on serum lipid levels.

Authors:  Rui-Xing Yin; Yi-Yang Li; Wan-Ying Liu; Lin Zhang; Jin-Zhen Wu
Journal:  PLoS One       Date:  2011-03-14       Impact factor: 3.240

Review 7.  Alcohol and cardiovascular disease--modulation of vascular cell function.

Authors:  Paul A Cahill; Eileen M Redmond
Journal:  Nutrients       Date:  2012-04-19       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.